Neuburgh Advisers’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$253K Hold
11,418
0.01% 620
2019
Q2
$236K Buy
11,418
+2,046
+22% +$47.2K 0.01% 647
2019
Q1
$270K Hold
9,372
0.01% 608
2018
Q4
$161K Buy
9,372
+330
+4% +$7.99K 0.01% 684
2018
Q3
$257K Buy
9,042
+1,694
+23% +$55.9K 0.01% 646
2018
Q2
$247K Hold
7,348
0.01% 593
2018
Q1
$178K Hold
7,348
0.01% 678
2017
Q4
$111K Buy
7,348
+1,584
+27% +$22.3K ﹤0.01% 773
2017
Q3
$95K Buy
5,764
+660
+13% +$11.2K ﹤0.01% 767
2017
Q2
$99K Buy
5,104
+2,024
+66% +$35.3K ﹤0.01% 732
2017
Q1
$55K Buy
3,080
+418
+16% +$7.75K ﹤0.01% 743
2016
Q4
$39K Buy
+2,662
New +$47.8K ﹤0.01% 778

Other funds holding THC

Neuburgh Advisers's THC Position: Q3 2019 in Review

Neuburgh Advisers held its Tenet Healthcare (THC) position steady in Q3 2019 at 11,418 shares worth $253K. The position accounts for 0.01% of the portfolio, ranked #620.

Neuburgh Advisers first reported a position in THC in Q4 2016 and has held it in 12 quarters since. The position peaked at $270K in Q1 2019. 246 funds tracked by Wall St. Rank hold THC as of Q3 2019.

  • Neuburgh Advisers held 11,418 shares of Tenet Healthcare worth $253K as of Q3 2019.
  • Neuburgh Advisers left its Tenet Healthcare share count unchanged in Q3 2019.
  • Tenet Healthcare made up 0.01% of Neuburgh Advisers's portfolio in Q3 2019, its #620 holding.
  • Neuburgh Advisers first reported a position in Tenet Healthcare in Q4 2016 and has held it in 12 quarters since.
  • Neuburgh Advisers's Tenet Healthcare position peaked at $270K in Q1 2019.
  • 246 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2019.

Based on Neuburgh Advisers's 13F filing for Q3 2019, filed 14 Nov 2019.